
        <!DOCTYPE html>
    <html lang="ja">
    <style>
    body
    {
        color: black;
        background-color: white;
    }
    div{
        font-size: 14px;
    }
    span
    {
        font-size: 18px;
    }
    #grad1{
        background: linear-gradient(transparent 60%,#99e4f1 30%);
        font-size: 18px;
        font-weight: bold;
    }
    #grad2{
        background: linear-gradient(transparent 60%,#fda1a1 30%);
        font-size: 18px;
        font-weight: bold;
    }

    </style>

    <head>
        <meta charset="UTF-8">
        <title>104-264</title>
    </head>

    <body>
        <h1>
        <a href="./104_263.html" rel="external" title="prev">≪</a>
        104-264
        <a href="./104_265.html" rel="external" title="next">≫</a>
        </h1>
        <div class='problem'>
            <p>
                <span id="grad1">　問題文　</span>
            </p>
            <p>
                <p>前問で選んだ薬剤について、薬剤師が患者に行う説明として最も適切なのはどれか。1つ選べ。</p>
<ol><li>尿に糖を出す薬です。</li><li>消化管からの糖の吸収を抑える薬です。</li><li>インスリンの分解を抑える薬です。</li><li>肝臓で糖ができるのを抑える薬です。</li><li>血糖値に応じてインスリンの分泌を促進する薬です。</li></ol>    
            </p>
        </div>
        <hr>

        <input type="button" value="check ans" onclick="toggle_switch()"/>
        
        <div id='toggle'>
        <div class='answer'>
            <p>
                <span id="grad2">　解答　　</span>
            </p>
            <p>
            問264：2, 4問265：5問266：5問267：5
            </p>
        </div>
        <div class='description'>
            <p>
                <span id="grad2">　解説　　</span>
            </p>
            <h4>問264</h4>
<p><span style="font-weight: 400;">選択肢 1 ですが<br/></span><span style="font-weight: 400;">メトホルミンの排泄には、尿細管への分泌が大きく寄与することが知られています。「主に糸球体ろ過」ではありません。よって、選択肢 1 は誤りです。</span></p>
<p><span style="font-weight: 400;">選択肢 2 は妥当な記述です。<br/></span><span style="font-weight: 400;">AUC と CL の関係は</span><b>「全身 CL  = D/AUC」</b><span style="font-weight: 400;"> です。これは基本知識です。この患者の eGFR は低いので、下の行を使います。D は 500mg で、バイオアベイラビリティが 60% なので、500 × 0.6 = 300 です。AUC は 1800 mg・min/L なので 300/1800 です。クリアランスの単位が mL/min なので、分母を 1800 → 1.8 にして計算すれば 約 170 です。</span></p>
<p><span style="font-weight: 400;">選択肢 3 ですが<br/></span><span style="font-weight: 400;">尿中排泄率とは、全身 CL における、腎クリアランスの割合です。腎機能正常群と 低下群を比べた時、まず全身クリアランスが 300/600 → 300/1800 と、1/3 におちていることがわかります。（ 「全身 CL  = D/AUC」 です。）</span></p>
<p><span style="font-weight: 400;">そして、腎クリアランスも 475 → 145 なので、大体 1/3 におちています。すると全体も、腎クリアランスも ほぼ 1/3 なので、占める割合はほぼ変化していないと考えられます。（適当な数値例としては、90/300 → 30/100 みたいな変化ということです。分母・分子が共に 1/3 になっているので、結局割合は変化していません。）よって、選択肢 3 は誤りです。</span></p>
<p><span style="font-weight: 400;">選択肢 4 は妥当な記述です。<br/></span><b>「Css = (D/τ）/全身CL」</b><span style="font-weight: 400;">です。定常状態の血中濃度に関するこの公式は超頻出基礎知識です。全身 CL が 1/3 なので、Css は約 3 倍と予想されます。</span></p>
<p><span style="font-weight: 400;">選択肢 5 ですが<br/></span><b>「Css = (D/τ）/全身CL」</b><span style="font-weight: 400;">です。 D = 300mg、τ = 12h、全身 CL 170mL/min を代入して計算します。</span></p>
<p><img alt="" class="alignnone size-full wp-image-4139" height="254.79999999999998" loading="lazy" sizes="(max-width: 474px) 100vw, 474px" src="data:;base64,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" width="331.79999999999995"/></p>
<p><span style="font-weight: 400;">1mg = 1000 μg なので 1000/408 です。明らかに 「約10μg/mL」ではありません。よって、選択肢 5 は誤りです。</span></p>
<p><span style="font-weight: 400;">以上より、問264 の正解は 2,4 です。</span></p>
<h4>問265</h4>
<p><span style="font-weight: 400;">メトホルミンの代表的な副作用は乳酸アシドーシスです。メトホルミンの作用機序は、AMP 依存性プロテインキナーゼを活性化し肝臓での糖新生を抑制です。</span></p>
<p><span style="font-weight: 400;">以上より、問265 の正解は 5 です。</span><span style="font-weight: 400;"><br/></span></p>
<h4>問266</h4>
<p><span style="font-weight: 400;">腎機能が相当落ちていることから、未変化体、代謝物も含めて、最も腎排泄されないものを選択肢して提案すべきと考えられます。表よりリナグリプチンが適切です。</span></p>
<p><span style="font-weight: 400;">以上より、正解は 5 です。</span></p>
<h4>問267</h4>
<p><span style="font-weight: 400;">リナグリプチンは、◯◯グリプチンなので、DPP－4選択的阻害薬です。DPP-4 は、腸管ホルモンであるインクレチンというホルモンを不活化するような酵素（セリンプロテアーゼ）です。この DPP-4 を阻害することによりインクレチンの働きを間接的に助けることでインスリン分泌が促進されます。</span></p>
<p><span style="font-weight: 400;">この薬の特徴として、インスリン分泌の調節が、グルコース濃度依存的に行われるという点が上げられます。すなわち、高血糖の時のみ、この薬は作用するのです。糖尿病治療薬につきものであった副作用である低血糖が起こりにくい薬としてDPP-4 阻害薬は知られています。</span></p>
<p><span style="font-weight: 400;">以上より、問 267 の正解は 5 です。</span></p>
            </p>
        </div>
        </div>
    </body>
    <script>
    document.getElementById("toggle").style.display="none";
    function toggle_switch(){
        var x = document.getElementById("toggle");
        if (x.style.display=="block"){
            x.style.display="none";
        }
        else{
            x.style.display="block";
        }
    }
    </script>
    